Skip to Content

Medtronic PLC MDT

Morningstar Rating
$85.06 +1.46 (1.75%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

MDT is trading at a 24% discount.
Price
$85.06
Fair Value
$637.00
Uncertainty
Medium
1-Star Price
$733.50
5-Star Price
$72.70
Economic Moat
Ylky
Capital Allocation
Sfmlxqn

Bulls Say, Bears Say

Bulls

Medtronic has historically held roughly 50% share in its core heart devices. It's also the market leader in spinal products, insulin pumps, and neuromodulators for chronic pain.

Bears

As smaller firms introduce new insulin pump technology, Medtronic may face a stiffer fight to maintain its leadership in this arena.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$83.60
Day Range
$83.2485.11
52-Week Range
$68.8492.02
Bid/Ask
$84.25 / $85.16
Market Cap
$112.94 Bil
Volume/Avg
5.6 Mil / 6.1 Mil

Key Statistics

Price/Earnings (Normalized)
15.72
Price/Sales
3.51
Dividend Yield (Trailing)
3.23%
Dividend Yield (Forward)
3.24%
Total Yield
3.50%

Company Profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Value
Total Number of Employees
95,000

Competitors

Valuation

Metric
MDT
ABT
BSX
Price/Earnings (Normalized)
15.7227.0432.89
Price/Book Value
2.185.395.13
Price/Sales
3.515.236.93
Price/Cash Flow
15.4821.5630.14
Price/Earnings
MDT
ABT
BSX

Financial Strength

Metric
MDT
ABT
BSX
Quick Ratio
1.461.160.63
Current Ratio
2.301.641.32
Interest Coverage
8.8610.868.41
Quick Ratio
MDT
ABT
BSX

Profitability

Metric
MDT
ABT
BSX
Return on Assets (Normalized)
7.75%10.63%8.92%
Return on Equity (Normalized)
13.75%20.87%16.33%
Return on Invested Capital (Normalized)
9.87%14.81%11.43%
Return on Assets
MDT
ABT
BSX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesRhzwtr$208.3 Bil
SYK
Stryker CorpNpp$135.3 Bil
BSX
Boston Scientific CorpYkvjpf$98.9 Bil
EW
Edwards Lifesciences CorpSrrnvf$52.3 Bil
DXCM
DexCom IncSrnt$47.1 Bil
ZBH
Zimmer Biomet Holdings IncNtmfp$25.7 Bil
ALGN
Align Technology IncGqnhpxz$23.1 Bil
PHG
Koninklijke Philips NV ADRXqzbk$18.4 Bil
PODD
Insulet CorpCptjhy$11.7 Bil

Sponsor Center